Clinical Trial Update: Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing CinnaGen Beta Erythropoietin (CinnaPoietin) to Eprex for treating anemia in ESRD patients on hemodialysis; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia in End-stage Renal Disease

Drugs mentioned

• CinnaPoietin (erythropoietin)
• Eprex (epoetin alfa)

Snippet

Sponsor: Cinnagen | Conditions: Anemia in End-Stage Renal Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-11-06